Results 131 to 140 of about 8,581 (194)

Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia. [PDF]

Commun Biol
Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M.   +9 more
europepmc   +1 more source

Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care. [PDF]

Curr Psychiatry Rep
Geller JA, Pacilio R, Downey AE, Ragnhildstveit A, Raymond-Flesch M, Knatz-Peck S, Gukasyan N.   +6 more
europepmc   +1 more source

Absence of psilocybin in species of fungi previously reported to contain psilocybin and related tryptamine derivatives.

, 1988
Seven taxa of agarics reported in literature to contain psilocybin (viz. Psathyrella candolleana, Gymnopilus spectabilis, G. fulgens, Hygrocybe psittacina var. psittacina and var. californica, Rickenella fibula, R.
Kuyper, Thomas, Stijve, T., Kuyper, Th.W.   +2 more
core  

Correction: Catatonia Associated With First-Time Psilocybin Exposure: A Case Report. [PDF]

Cureus
Singh J, Mruthyunjaya P.
europepmc   +1 more source

Prevalence and Correlates of Past-Year Psilocybin Use in the United States. [PDF]

Am J Psychiatry
Yang KH, Eun A, Palamar JJ.
europepmc   +1 more source

Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization. [PDF]

Front Psychiatry
Yu F, Tafur J, Moreno F, Dahmer S.
europepmc   +1 more source

The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov

Sarah A Norring,* Michael G Spigarelli* PsyBio Therapeutics, Inc., Sunrise, FL, USA*These authors contributed equally to this workCorrespondence: Sarah A Norring, Director of Program Management for PsyBio Therapeutics, Inc., 3130 N Pine ...
Norring SA, Spigarelli MG
core  

Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation. [PDF]

Healthcare (Basel)
Dorval M, Audet-Croteau V, Chang SL, Masse-Grenier M, Tremblay A, Bénard E, Chapdelaine A, Garel N, Guertin JR.   +8 more
europepmc   +1 more source

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults. [PDF]

Am J Prev Med
Yang KH, Satybaldiyeva N, Kepner W, Friedman J, Ping S, Leas EC.   +5 more
europepmc   +1 more source

Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland. [PDF]

Int J Neuropsychopharmacol
Kelly JR, Sheridan C, Iusan P, Coakley L, Burke L, Brennan C, MacDonald A, Ivers JH, Trepel D, Tormey G, Finnegan M, Young GW, Harkin A.   +12 more
europepmc   +1 more source